Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 38 entries
Sorted by: Best Match Show Resources per page
Does disaster education of teenagers translate into better survival knowledge, knowledge of skills, and adaptive behavioral change? A systematic literature review

discipline specific-education (e.g., chemistry education, biology education, economics education)

Codreanu TA, Celenza A.
GSID: ed8_EqajBygJ
TA Codreanu, A Celenza, I Jacobs - Prehospital and disaster …, 2014 - cambridge.org

… Not only are their special biological, anatomical, and physiological characteristics working … needs,6 while in others (eg, Indonesia), disaster education in public schools has not been … Earthquake-specific education was evaluated in seven studies (50%), all hazards education...

Cite
Codreanu, T. A., Celenza, A., & Jacobs, I. (2014). Does disaster education of teenagers translate into better survival knowledge, knowledge of skills, and adaptive behavioral change? A systematic literature review. Prehospital and disaster medicine, 29(6), 629-642.
Codreanu, Tudor A., Antonio Celenza, and Ian Jacobs. "Does disaster education of teenagers translate into better survival knowledge, knowledge of skills, and adaptive behavioral change? A systematic literature review." Prehospital and disaster medicine 29.6 (2014): 629-642.
Copy Download .nbib Format: MLA
Suppression of Chaos in a One-dimensional Mapping.

Journal of biological physics

Codreanu S, Danca M.
PMID: 23345646
J Biol Phys. 1997 Mar;23(1):1-9. doi: 10.1023/A:1004910118920.

The suppression of chaos in an one-dimensional model of malignant tumor growth is presented. As a result, a steady-state and differentperiodic motions, embedded in the chaotic attractor, arestabilized.

Cite
Codreanu S, Danca M. Suppression of Chaos in a One-dimensional Mapping. J Biol Phys. 1997;23(1):1-9doi: 10.1023/A:1004910118920.
Codreanu, S., & Danca, M. (1997). Suppression of Chaos in a One-dimensional Mapping. Journal of biological physics, 23(1), 1-9. https://doi.org/10.1023/A:1004910118920
Codreanu, S, and Danca, M. "Suppression of Chaos in a One-dimensional Mapping." Journal of biological physics vol. 23,1 (1997): 1-9. doi: https://doi.org/10.1023/A:1004910118920
Codreanu S, Danca M. Suppression of Chaos in a One-dimensional Mapping. J Biol Phys. 1997 Mar;23(1):1-9. doi: 10.1023/A:1004910118920. PMID: 23345646; PMCID: PMC3456266.
Copy Download .nbib Format: NLM
Engineered microfluidic bioreactor for examining the three-dimensional breast tumor microenvironment.

Biomicrofluidics

Rogers M, Sobolik T, Schaffer DK, Samson PC, Johnson AC, Owens P, Codreanu SG, Sherrod SD, McLean JA, Wikswo JP, Richmond A.
PMID: 29774083
Biomicrofluidics. 2018 May 07;12(3):034102. doi: 10.1063/1.5016433. eCollection 2018 May.

The interaction of cancer cells with the stromal cells and matrix in the tumor microenvironment plays a key role in progression to metastasis. A better understanding of the mechanisms underlying these interactions would aid in developing new therapeutic approaches...

Cite
Rogers M, Sobolik T, Schaffer DK, et al. Engineered microfluidic bioreactor for examining the three-dimensional breast tumor microenvironment. Biomicrofluidics. 2018;12(3):034102doi: 10.1063/1.5016433.
Rogers, M., Sobolik, T., Schaffer, D. K., Samson, P. C., Johnson, A. C., Owens, P., Codreanu, S. G., Sherrod, S. D., McLean, J. A., Wikswo, J. P., & Richmond, A. (2018). Engineered microfluidic bioreactor for examining the three-dimensional breast tumor microenvironment. Biomicrofluidics, 12(3), 034102. https://doi.org/10.1063/1.5016433
Rogers, Matthew, et al. "Engineered microfluidic bioreactor for examining the three-dimensional breast tumor microenvironment." Biomicrofluidics vol. 12,3 (2018): 034102. doi: https://doi.org/10.1063/1.5016433
Rogers M, Sobolik T, Schaffer DK, Samson PC, Johnson AC, Owens P, Codreanu SG, Sherrod SD, McLean JA, Wikswo JP, Richmond A. Engineered microfluidic bioreactor for examining the three-dimensional breast tumor microenvironment. Biomicrofluidics. 2018 May 07;12(3):034102. doi: 10.1063/1.5016433. eCollection 2018 May. PMID: 29774083; PMCID: PMC5938175.
Copy Download .nbib Format: NLM
Probing morphological, genetic and metabolomic changes of in vitro embryo development in a microfluidic device.

Biotechnology progress

Mancini V, McKeegan PJ, Schrimpe-Rutledge AC, Codreanu SG, Sherrod SD, McLean JA, Picton HM, Pensabene V.
PMID: 34288603
Biotechnol Prog. 2021 Nov;37(6):e3194. doi: 10.1002/btpr.3194. Epub 2021 Jul 29.

Assisted reproduction technologies for clinical and research purposes rely on a brief in vitro embryo culture which, despite decades of progress, remain suboptimal in comparison to the physiological environment. One promising tool to improve this technique is the development...

Cite
Mancini V, McKeegan PJ, Schrimpe-Rutledge AC, et al. Probing morphological, genetic and metabolomic changes of in vitro embryo development in a microfluidic device. Biotechnol Prog. 2021;37(6):e3194doi: 10.1002/btpr.3194.
Mancini, V., McKeegan, P. J., Schrimpe-Rutledge, A. C., Codreanu, S. G., Sherrod, S. D., McLean, J. A., Picton, H. M., & Pensabene, V. (2021). Probing morphological, genetic and metabolomic changes of in vitro embryo development in a microfluidic device. Biotechnology progress, 37(6), e3194. https://doi.org/10.1002/btpr.3194
Mancini, Vanessa, et al. "Probing morphological, genetic and metabolomic changes of in vitro embryo development in a microfluidic device." Biotechnology progress vol. 37,6 (2021): e3194. doi: https://doi.org/10.1002/btpr.3194
Mancini V, McKeegan PJ, Schrimpe-Rutledge AC, Codreanu SG, Sherrod SD, McLean JA, Picton HM, Pensabene V. Probing morphological, genetic and metabolomic changes of in vitro embryo development in a microfluidic device. Biotechnol Prog. 2021 Nov;37(6):e3194. doi: 10.1002/btpr.3194. Epub 2021 Jul 29. PMID: 34288603.
Copy Download .nbib Format: NLM
Molecular Detection of .

Journal of clinical medicine

Molina-Moya B, Ciobanu N, Hernandez M, Prat-Aymerich C, Crudu V, Adams ER, Codreanu A, Sloan DJ, Cuevas LE, Dominguez J.
PMID: 33371314
J Clin Med. 2020 Dec 21;9(12). doi: 10.3390/jcm9124124.

Tuberculosis (TB) diagnosis is increasingly based on the detection of

Cite
Molina-Moya B, Ciobanu N, Hernandez M, et al. Molecular Detection of . J Clin Med. 2020;9(12)doi: 10.3390/jcm9124124.
Molina-Moya, B., Ciobanu, N., Hernandez, M., Prat-Aymerich, C., Crudu, V., Adams, E. R., Codreanu, A., Sloan, D. J., Cuevas, L. E., & Dominguez, J. (2020). Molecular Detection of . Journal of clinical medicine, 9(12), . https://doi.org/10.3390/jcm9124124
Molina-Moya, Barbara, et al. "Molecular Detection of ." Journal of clinical medicine vol. 9,12 (2020). doi: https://doi.org/10.3390/jcm9124124
Molina-Moya B, Ciobanu N, Hernandez M, Prat-Aymerich C, Crudu V, Adams ER, Codreanu A, Sloan DJ, Cuevas LE, Dominguez J. Molecular Detection of . J Clin Med. 2020 Dec 21;9(12). doi: 10.3390/jcm9124124. PMID: 33371314; PMCID: PMC7767357.
Copy Download .nbib Format: NLM
Upadacitinib .

Drugs in context

Pavelka K, Szekanecz Z, Damjanov N, Anić B, Tomšič M, Mazurov V, Maksimovic M, Nagy O, Świerkot J, Petranova T, Veldi T, Baranauskaitė A, Codreanu C, Andersone D, Fleischmann R.
PMID: 33123205
Drugs Context. 2020 Oct 19;9. doi: 10.7573/dic.2020-7-5. eCollection 2020.

BACKGROUND: In the randomized, phase III, global SELECT-COMPARE study, upadacitinib 15 mg demonstrated efficacy at week 12 METHODS: Patients were randomized 2:2:1 to upadacitinib 15 mg once daily, placebo, or adalimumab 40 mg every other week, and continued MTX....

Cite
Pavelka K, Szekanecz Z, Damjanov N, et al. Upadacitinib . Drugs Context. 2020;9doi: 10.7573/dic.2020-7-5.
Pavelka, K., Szekanecz, Z., Damjanov, N., Anić, B., Tomšič, M., Mazurov, V., Maksimovic, M., Nagy, O., Świerkot, J., Petranova, T., Veldi, T., Baranauskaitė, A., Codreanu, C., Andersone, D., & Fleischmann, R. (2020). Upadacitinib . Drugs in context, 9. https://doi.org/10.7573/dic.2020-7-5
Pavelka, Karel, et al. "Upadacitinib ." Drugs in context vol. 9 (2020). doi: https://doi.org/10.7573/dic.2020-7-5
Pavelka K, Szekanecz Z, Damjanov N, Anić B, Tomšič M, Mazurov V, Maksimovic M, Nagy O, Świerkot J, Petranova T, Veldi T, Baranauskaitė A, Codreanu C, Andersone D, Fleischmann R. Upadacitinib . Drugs Context. 2020 Oct 19;9. doi: 10.7573/dic.2020-7-5. eCollection 2020. PMID: 33123205; PMCID: PMC7574850.
Copy Download .nbib Format: NLM
Local Fibrinolysis in Spontaneous Supratentorial Hematomas: Comparison with Surgical and Medical Treatment.

Interventional neurology

Condrea E, Timirgaz V, Groppa S, Codreanu I, Rotaru N.
PMID: 27781045
Interv Neurol. 2016 Sep;5(3):165-173. doi: 10.1159/000447310. Epub 2016 Jul 01.

OBJECTIVE: To evaluate the effectiveness of minimally invasive craniopuncture with local fibrinolysis in the management of supratentorial spontaneous intracerebral hemorrhage (SICH).METHODS: The study included 218 consecutive patients with supratentorial SICH who were assigned to one of three groups: treated...

Cite
Condrea E, Timirgaz V, Groppa S, et al. Local Fibrinolysis in Spontaneous Supratentorial Hematomas: Comparison with Surgical and Medical Treatment. Interv Neurol. 2016;5(3):165-173doi: 10.1159/000447310.
Condrea, E., Timirgaz, V., Groppa, S., Codreanu, I., & Rotaru, N. (2016). Local Fibrinolysis in Spontaneous Supratentorial Hematomas: Comparison with Surgical and Medical Treatment. Interventional neurology, 5(3), 165-173. https://doi.org/10.1159/000447310
Condrea, Eugeniu, et al. "Local Fibrinolysis in Spontaneous Supratentorial Hematomas: Comparison with Surgical and Medical Treatment." Interventional neurology vol. 5,3 (2016): 165-173. doi: https://doi.org/10.1159/000447310
Condrea E, Timirgaz V, Groppa S, Codreanu I, Rotaru N. Local Fibrinolysis in Spontaneous Supratentorial Hematomas: Comparison with Surgical and Medical Treatment. Interv Neurol. 2016 Sep;5(3):165-173. doi: 10.1159/000447310. Epub 2016 Jul 01. PMID: 27781045; PMCID: PMC5075811.
Copy Download .nbib Format: NLM
Evaluating the Diagnostic Paradigm for Group A and Non-Group A Streptococcal Pharyngitis in the College Student Population.

Open forum infectious diseases

Rich SN, Prosperi M, Klann EM, Codreanu PT, Cook RL, Turley MK.
PMID: 34805428
Open Forum Infect Dis. 2021 Nov 16;8(11):ofab482. doi: 10.1093/ofid/ofab482. eCollection 2021 Nov.

BACKGROUND: Acute pharyngitis is a frequent illness presenting in outpatient settings. Antibiotics are only recommended for bacterial pharyngitis caused by group A β-hemolytic streptococci (GAS); however, infections with non-group A β-hemolytic streptococci (NGAS) have similar clinical presentations and are...

Cite
Rich SN, Prosperi M, Klann EM, et al. Evaluating the Diagnostic Paradigm for Group A and Non-Group A Streptococcal Pharyngitis in the College Student Population. Open Forum Infect Dis. 2021;8(11):ofab482doi: 10.1093/ofid/ofab482.
Rich, S. N., Prosperi, M., Klann, E. M., Codreanu, P. T., Cook, R. L., & Turley, M. K. (2021). Evaluating the Diagnostic Paradigm for Group A and Non-Group A Streptococcal Pharyngitis in the College Student Population. Open forum infectious diseases, 8(11), ofab482. https://doi.org/10.1093/ofid/ofab482
Rich, Shannan N, et al. "Evaluating the Diagnostic Paradigm for Group A and Non-Group A Streptococcal Pharyngitis in the College Student Population." Open forum infectious diseases vol. 8,11 (2021): ofab482. doi: https://doi.org/10.1093/ofid/ofab482
Rich SN, Prosperi M, Klann EM, Codreanu PT, Cook RL, Turley MK. Evaluating the Diagnostic Paradigm for Group A and Non-Group A Streptococcal Pharyngitis in the College Student Population. Open Forum Infect Dis. 2021 Nov 16;8(11):ofab482. doi: 10.1093/ofid/ofab482. eCollection 2021 Nov. PMID: 34805428; PMCID: PMC8599756.
Copy Download .nbib Format: NLM
Prevention programmes of progressive renal disease in developing nations.

Nephrology (Carlton, Vic.)

Codreanu I, Perico N, Sharma SK, Schieppati A, Remuzzi G.
PMID: 16889572
Nephrology (Carlton). 2006 Aug;11(4):321-8. doi: 10.1111/j.1440-1797.2006.00587.x.

Development of strategies for the early detection and prevention of non-communicable diseases, including kidney disease, is the only realistic strategy to avert an imminent global health and economic crisis and enhance equity in health care worldwide. In this article,...

Cite
Codreanu I, Perico N, Sharma SK, et al. Prevention programmes of progressive renal disease in developing nations. Nephrology (Carlton). 2006;11(4):321-8doi: 10.1111/j.1440-1797.2006.00587.x.
Codreanu, I., Perico, N., Sharma, S. K., Schieppati, A., & Remuzzi, G. (2006). Prevention programmes of progressive renal disease in developing nations. Nephrology (Carlton, Vic.), 11(4), 321-8. https://doi.org/10.1111/j.1440-1797.2006.00587.x
Codreanu, Igor, et al. "Prevention programmes of progressive renal disease in developing nations." Nephrology (Carlton, Vic.) vol. 11,4 (2006): 321-8. doi: https://doi.org/10.1111/j.1440-1797.2006.00587.x
Codreanu I, Perico N, Sharma SK, Schieppati A, Remuzzi G. Prevention programmes of progressive renal disease in developing nations. Nephrology (Carlton). 2006 Aug;11(4):321-8. doi: 10.1111/j.1440-1797.2006.00587.x. PMID: 16889572.
Copy Download .nbib Format: NLM
Protection of Human Beings Trafficked for the Purpose of Organ Removal: Recommendations.

Transplantation direct

Pascalev A, Van Assche K, Sándor J, Codreanu N, Naqvi A, Gunnarson M, Frunza M, Yankov J.
PMID: 27500252
Transplant Direct. 2016 Jan 04;2(2):e59. doi: 10.1097/TXD.0000000000000565. eCollection 2016 Feb.

This report presents a comprehensive set of recommendations for protection of human beings who are trafficked for the purpose of organ removal or are targeted for such trafficking. Developed by an interdisciplinary group of international experts under the auspices...

Cite
Pascalev A, Van Assche K, Sándor J, et al. Protection of Human Beings Trafficked for the Purpose of Organ Removal: Recommendations. Transplant Direct. 2016;2(2):e59doi: 10.1097/TXD.0000000000000565.
Pascalev, A., Van Assche, K., Sándor, J., Codreanu, N., Naqvi, A., Gunnarson, M., Frunza, M., & Yankov, J. (2016). Protection of Human Beings Trafficked for the Purpose of Organ Removal: Recommendations. Transplantation direct, 2(2), e59. https://doi.org/10.1097/TXD.0000000000000565
Pascalev, Assya, et al. "Protection of Human Beings Trafficked for the Purpose of Organ Removal: Recommendations." Transplantation direct vol. 2,2 (2016): e59. doi: https://doi.org/10.1097/TXD.0000000000000565
Pascalev A, Van Assche K, Sándor J, Codreanu N, Naqvi A, Gunnarson M, Frunza M, Yankov J. Protection of Human Beings Trafficked for the Purpose of Organ Removal: Recommendations. Transplant Direct. 2016 Jan 04;2(2):e59. doi: 10.1097/TXD.0000000000000565. eCollection 2016 Feb. PMID: 27500252; PMCID: PMC4946495.
Copy Download .nbib Format: NLM
Cost-Effectiveness of Certolizumab Pegol in the Treatment of Active Rheumatoid Arthritis, Axial Spondyloarthritis, and Psoriatic Arthritis In Romania.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Codreanu C, Mogosanu C, Joita M, Purcaru O.
PMID: 27200835
Value Health. 2014 Nov;17(7):A379. doi: 10.1016/j.jval.2014.08.2608. Epub 2014 Oct 26.

No abstract available.

Cite
Codreanu C, Mogosanu C, Joita M, et al. Cost-Effectiveness of Certolizumab Pegol in the Treatment of Active Rheumatoid Arthritis, Axial Spondyloarthritis, and Psoriatic Arthritis In Romania. Value Health. 2014;17(7):A379doi: 10.1016/j.jval.2014.08.2608.
Codreanu, C., Mogosanu, C., Joita, M., & Purcaru, O. (2014). Cost-Effectiveness of Certolizumab Pegol in the Treatment of Active Rheumatoid Arthritis, Axial Spondyloarthritis, and Psoriatic Arthritis In Romania. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A379. https://doi.org/10.1016/j.jval.2014.08.2608
Codreanu, C, et al. "Cost-Effectiveness of Certolizumab Pegol in the Treatment of Active Rheumatoid Arthritis, Axial Spondyloarthritis, and Psoriatic Arthritis In Romania." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A379. doi: https://doi.org/10.1016/j.jval.2014.08.2608
Codreanu C, Mogosanu C, Joita M, Purcaru O. Cost-Effectiveness of Certolizumab Pegol in the Treatment of Active Rheumatoid Arthritis, Axial Spondyloarthritis, and Psoriatic Arthritis In Romania. Value Health. 2014 Nov;17(7):A379. doi: 10.1016/j.jval.2014.08.2608. Epub 2014 Oct 26. PMID: 27200835.
Copy Download .nbib Format: NLM
Global untargeted serum metabolomic analyses nominate metabolic pathways responsive to loss of expression of the orphan metallo β-lactamase, MBLAC1.

Molecular omics

Gibson CL, Codreanu SG, Schrimpe-Rutledge AC, Retzlaff CL, Wright J, Mortlock DP, Sherrod SD, McLean JA, Blakely RD.
PMID: 29868674
Mol Omics. 2018 Jun 12;14(3):142-155. doi: 10.1039/c7mo00022g.

The C. elegans gene swip-10 encodes an orphan metallo β-lactamase that genetic studies indicate is vital for limiting neuronal excitability and viability. Sequence analysis indicates that the mammalian gene Mblac1 is the likely ortholog of swip-10, with greatest sequence...

Cite
Gibson CL, Codreanu SG, Schrimpe-Rutledge AC, et al. Global untargeted serum metabolomic analyses nominate metabolic pathways responsive to loss of expression of the orphan metallo β-lactamase, MBLAC1. Mol Omics. 2018;14(3):142-155doi: 10.1039/c7mo00022g.
Gibson, C. L., Codreanu, S. G., Schrimpe-Rutledge, A. C., Retzlaff, C. L., Wright, J., Mortlock, D. P., Sherrod, S. D., McLean, J. A., & Blakely, R. D. (2018). Global untargeted serum metabolomic analyses nominate metabolic pathways responsive to loss of expression of the orphan metallo β-lactamase, MBLAC1. Molecular omics, 14(3), 142-155. https://doi.org/10.1039/c7mo00022g
Gibson, Chelsea L, et al. "Global untargeted serum metabolomic analyses nominate metabolic pathways responsive to loss of expression of the orphan metallo β-lactamase, MBLAC1." Molecular omics vol. 14,3 (2018): 142-155. doi: https://doi.org/10.1039/c7mo00022g
Gibson CL, Codreanu SG, Schrimpe-Rutledge AC, Retzlaff CL, Wright J, Mortlock DP, Sherrod SD, McLean JA, Blakely RD. Global untargeted serum metabolomic analyses nominate metabolic pathways responsive to loss of expression of the orphan metallo β-lactamase, MBLAC1. Mol Omics. 2018 Jun 12;14(3):142-155. doi: 10.1039/c7mo00022g. PMID: 29868674; PMCID: PMC6015503.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 38 entries